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A B S T R A C T
Background
Chronic obstructive pulmonary disease (COPD) is a disease of irreversible airways obstruction in which patients often suffer exacerba-
tions. Sometimes these exacerbations need hospital care: telehealthcare has the potential to reduce admission to hospital when used to
administer care to the pateint from within their own home.
Objectives
To review the effectiveness of telehealthcare for COPD compared with usual face-to-face care.
Search methods
We searched the Cochrane Airways Group Specialised Register, which is derived from systematic searches of the Cochrane Central
Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, CINAHL, AMED, and PsycINFO; last searched January 2010.
Selection criteria
We selected randomised controlled trials which assessed telehealthcare, defined as follows: healthcare at a distance, involving the
communication of data from the patient to the health carer, usually a doctor or nurse, who then processes the information and responds
with feedback regarding the management of the illness. The primary outcomes considered were: number of exacerbations, quality of
life as recorded by the St George’s Respiratory Questionnaire, hospitalisations, emergency department visits and deaths.
Data collection and analysis
Two authors independently selected trials for inclusion and extracted data. We combined data into forest plots using fixed-effects
modelling as heterogeneity was low (I2 < 40%).
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Main results
Ten trials met the inclusion criteria. Telehealthcare was assessed as part of a complex intervention, including nurse case management
and other interventions. Telehealthcare was associated with a clinically significant increase in quality of life in two trials with 253
participants (mean difference -6.57 (95% confidence interval (CI) -13.62 to 0.48); minimum clinically significant difference is a change
of -4.0), but the confidence interval was wide. Telehealthcare showed a significant reduction in the number of patients with one or more
emergency department attendances over 12 months; odds ratio (OR) 0.27 (95% CI 0.11 to 0.66) in three trials with 449 participants,
and the OR of having one or more admissions to hospital over 12 months was 0.46 (95% CI 0.33 to 0.65) in six trials with 604
participants. There was no significant difference in the OR for deaths over 12 months for the telehealthcare group as compared to the
usual care group in three trials with 503 participants; OR 1.05 (95% CI 0.63 to 1.75).
Authors’ conclusions
Telehealthcare in COPD appears to have a possible impact on the quality of life of patients and the number of times patients attend
the emergency department and the hospital. However, further research is needed to clarify precisely its role since the trials included
telehealthcare as part of more complex packages.
P L A I N L A N G U A G E S U M M A R Y
Telehealthcare for COPD - bronchitis and emphysema
The smoking related diseases of bronchitis and emphysema are now considered under the umbrella term of chronic obstructive
pulmonary disease, COPD. This is because they are diseases which leave people breathless and often with a cough and increased
phlegm. Such people often have times when their COPD worsens and they cannot “get their breath” and have to go into hospital
for treatment. It is very expensive to look after people this way and often they do not want to spend time in hospital but there are
few alternatives. Telehealthcare involves using technology such as telephones, video cameras and the Internet to allow people to stay
at home and communicate with a nurse or doctor when they have a period of increased breathlessness. The professional can obtain
information from the patient to allow them to prescribe treatments and monitor the patient closely without them having to go into
hospital or to the emergency department. This study shows that people treated this way do manage to stay out of hospital longer than
people treated by conventional systems of care. There are also some data showing that although these systems are expensive to start off
with, if they are successful at keeping people out of hospital, then the cost saving from this means that they are cheaper in the long run.
B A C K G R O U N D
Description of the condition
The Global Initiative for Obstructive Lung Disease defines
Chronic Obstructive Pulmonary Disease, COPD, as follows:
“COPD is a preventable and treatable disease with some signif-
icant extrapulmonary effects that may contribute to the severity
in individual patients. Its pulmonary component is characterized
by airflow limitation that is not fully reversible. The airflow lim-
itation is usually progressive and associated with an abnormal in-
flammatory response of the lung to noxious particles or gases.”
(GOLD 2007)
COPD is an increasingly important disease globally. It is a classical
gene X environment disease, meaning that genetic susceptibility
is influenced by environmental factors resulting in the disease.
However, thinking about the pathogenesis of COPD has rapidly
evolved recently. Traditionally COPD has been considered to be a
disease of smokers. Long term lung damage results from exposure
to toxins in cigarette smoke and there is a loss of the elasticity
of the lung tissue. Recently there has been a broadening of the
concept of COPD to include the influence of other environmental
factors including exposure to industrial and biomass fuel toxins
(Mannino 2007).
The major feature of COPD is airflow limitation, measured and
classified using spirometry. As lung function declines from its peak
in the 3rd or 4th decade, and it progresses with age, it often results
in severe limitations to function once the patient is elderly. In
people with underlying susceptibility and smoke or dust exposure
the disease is frequently life-limiting.
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In addition, the extrapulmonary effects of COPD are increas-
ingly being seen as part of a systemic disease (The Lancet 2007).
These include muscle wasting, cardiovascular disease, depression,
reduced fat free mass, osteopenia and chronic infections. There
is increasing recognition that patients are more likely to die from
these co-morbidities than from the COPD alone.
The prevalence of COPD is very variable across different popu-
lations and global estimates of morbidity and mortality are often
underestimates due to poor recognition of COPD as a contributor
to the events (Mannino 2007).
In some countries, such as the UK (Pride 2002), there is good evi-
dence that hospital admissions for exacerbations and home oxygen
supplies account for significant healthcare costs.
The clinical course of COPD is that of an increasingly debilitated
trajectory as a result of airflow limitation. This is punctuated by
acute exacerbations of “shortness of breath”with increased sputum
production and reduced exercise tolerance. Often during these
exacerbations the patient is admitted to hospital for antibiotics
and inhaled therapies including oxygen support. It may take a
number of weeks for the patient to recover during which time they
lose muscle mass as a result of reduced activity. The rehabilitation
of the patient takes time and often does not achieve the level of
functioning they had before they were admitted to hospital. The
later years of COPD illness are often characterised by repeated
increasing periods spent in hospital (GOLD 2007).
Description of the intervention
It is clear that the terminology of “telehealthcare”, “telemedicine”,
and “telehealth” is growing rapidly and that there is significant
overlap between these terms (Busey 2008; HRSA; Mahen 2006).
For the purposes of this reviewwehave chosen todescribe the inter-
ventions undergoing study as “telehealthcare”. This termmost use-
fully encompasses a number of technologies previously described
under various terms such as “telehealth”, “telemedicine”, “telecare”
and “telenursing”.
The American Nursing Association argues that when a nurse is
providing care, “telenursing” is interchangeable with “telehealth”
because nurses still follow nursing processes by formulating care
plans and providing care using their nursing knowledge and skills.
For example, in videoconferencing this includes communication
skills such as picking up subtle clues from a patient’s tone of voice
and facial expression (Lorentz 2008).
We favour “telehealthcare” over the terms telemedicine and te-
lenursing as these latter terms imply a specific professional deliver-
ing the healthcare. Such roles are increasingly blurred and politi-
cised and trying to distinguish between them is therefore not par-
ticularly helpful. This intervention has as its focus the disease of
COPD and the aim of the studies should be to improve the pa-
tient’s COPD with the help of a doctor, nurse or allied healthcare
professional.
“Telehealthcare” has the following elements (adapted from Miller
2007):
1. information from the patient whether voice, video, other
audio, oxygen saturation, breath sounds or other;
2. electronic transfer of such information over a distance;
3. there is personalised feedback from a healthcare professional
who exercises their skills and judgement in the giving of tailored
advice to the patient.
Interventions captured within the terms telehealthcare include
synchronous interactions, e.g. telephone and videoconferencing
enabled consultations; and asynchronous care using store and for-
ward technology, e.g. storing two weeks worth of spirometry re-
sults then sending them on to a nurse who replies by email or
telephone.
We use telehealthcare to mean business to consumer or B2C com-
munication: i.e. communication involving an interaction between
a health professional and a patient with COPD. This is as opposed
to business-to-business communication or “B2B communication”
which might involve intraprofessional communication for second
opinions, this is sometimes referred to as telemedicine and is be-
yond the scope of our definition.
Also beyond the scope of our definition is passive information
provision, e.g. online education, where a healthcare professional
is not involved in an exchange with the patient.
How the intervention might work
Telehealthcare is a complex intervention as defined by the MRC
and therefore it can be difficult to pin down exactly what is the “ac-
tive ingredient” of the intervention. Typically, in COPD, there are
a number of ingredients including some education, some assisted
planning, emotional support, pragmatic advice, monitoring with
equipment, etc. which, taken together, may or may not benefit
the patient. We see the purpose of this review as being to establish
whether or not telehealthcare has a positive impact. Further, the-
oretical work, including qualitative studies will be required to un-
pick precisely how any effect is delivered. However, we have so far
found the following potential mechanisms through which quality
of care may be enhanced and cost savings achieved through the
use of telehealthcare, as adapted from Finkelstein 2000:
1. providing patient education and counselling for primary
prevention and early detection of COPD evolution;
2. improving adherence to medications and other treatment
regimens;
3. collecting patient data remotely;
4. replacing face-to-face nursing/physician visits;
5. providing early detection of incipient disease exacerbation
and timely intervention for early symptom management;
6. reducing unscheduled/unnecessary visits to the physician
and emergency room;
7. preventing and reducing repeat hospitalisations.
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Why it is important to do this review
In the economically-developed world many electronic tools for re-
motely helping patients with COPD are now being implemented
in the absence of an explicit evidence base. Exploration of the ex-
isting evidence of the values or risks of these interventions is there-
fore urgently required. A recent Cochrane assessment of telecon-
sultations compared with face-to-face consultations found little
evidence of clinical benefit, variable and inconclusive results for
other outcomes (psychological measures) and no analysable data of
cost-effectiveness. The authors concluded that further research is
clearly required (Currell 2008). Mair 2000b performed a system-
atic review regarding patient satisfaction with telehealthcare and
found that it was not clear precisely when telehealthcare might be
a feasible alternative for consultation or how telehealthcare might
impact on the patient’s relationship with their healthcare profes-
sional. Thus, the benefits of telehealthcare interventions are un-
quantified.
In addition, it is necessary to consider that the world’s rapidly
aging population means that there will be a stretching of health
and social care resources (Darzi 2008). Healthcare delivery needs
to becomemuchmore efficient. It is hoped that telehealthcare will
help meet such needs. Part of the rationale for telehealthcare is
that long term running costs may be lower than in conventional
care because early disease could be detected and treated, thereby
preventing ensuing morbidity and hospitalisations. In the case of
COPD, the potential exists to manage patients with exacerbations
largely in their own homes, thereby saving on hospitalisation costs.
Initial start-up costs of telehealthcare are thought to be substantial.
The number and quality of cost-effectiveness studies regarding
telehealthcare so far provide inadequate evidence of it as a cost-
effective means of delivering healthcare (Whitten 2002).
In addition, COPD can be an extremely debilitating disease and
patients with COPD can have limited quality of life. Telecommu-
nications such as those used in telehealthcare programmes hold
some promise for releasing such people from illness-imposed iso-
lation.
O B J E C T I V E S
To review the effectiveness of telehealthcare for COPD compared
with face-to-face usual care in improving quality of life and re-
ducing accident and emergency department visits and hospitali-
sations.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials which compared a tele-
healthcare intervention with a control group. We did not expect
studies to be blinded as participants were necessarily aware of the
interventions.
Types of participants
We chose studies where the focus was participants with COPD,
as diagnosed by a clinician, with no exclusions on the basis of age,
gender, ethnicity or language spoken.We considered both primary
and secondary care settings. We did not include studies of people
with asthma only.
Types of interventions
Interventions included the following examples of where pathways
had been set up using a telehealthcare mechanism. There was a
focus on the proactive use of technology to provide the information
the healthcare professional required to make their decisions. The
technology is central and its use was sustained.
1. Video or telephone links with healthcare professionals in
real time or using store and forward technologies.
2. Systems of care using Internet-based telecommunication
with healthcare professionals.
3. Systems of care using both wired and wireless telemetry for
telemonitoring of spirometry (FEV1/FVC), respiratory rate,
blood pressure and oxygen saturations involving feedback to the
patient, which has been processed or authorised by a healthcare
professional.
4. Other systems of remote healthcare.
5. Complex intervention studies if it is possible to tease out
the individual telehealthcare elements.
6. Interventions in all settings and from all types of healthcare
provider.
Excluded interventions would include:
1. Telehealthcare which is only educational without the input
of a professional, e.g. in an emergency waiting room.
2. Decision support which functions without the input of a
healthcare professional.
Types of outcome measures
Primary outcomes
• Total exacerbations.
• Quality of life (e.g. St George’s Respiratory Questionnaire).
• Emergency Department visits.
• Hospitalisations.
• Deaths.
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Secondary outcomes
• FEV1.
• FVC.
• Patient satisfaction.
• Study withdrawal.
• Costs.
• Cost effectiveness.
Search methods for identification of studies
Electronic searches
Trials were identified using the Cochrane Airways Group Spe-
cialised Register of trials, which is derived from systematic searches
of bibliographic databases including the Cochrane Central Reg-
ister of Controlled Trials (CENTRAL), MEDLINE, EMBASE,
CINAHL, AMED, and PsycINFO, and handsearching of respira-
tory journals andmeeting abstracts (please see the Airways Group
Module for further details).
All records in the Specialised Register coded as ’COPD’ were
searched using the following terms:
telehealth* or tele-health* or telemedicine* or tele-medicine* or
Internet* or computer* or web* or interactive* or telecommunica-
tion* or telephone or phone or SMS or tele-monitor* or telemon-
itor* or telemanagement or tele-management or teleconsultation
or tele-consultation or telecare* or tele-care* or telematic* or tele-
pharmacy or tele-pharmacy or telenurs* or tele-nurs* or video or
email or e-mail or “remote consult*” or wireless or bluetooth or
tele-homecare or telehomecare or “remote care” or tele-support or
telesupport or “mobile healthcare” or “computer mediated ther-
apy” or ehealth or e-health or mhealth or m-health
The search has been conducted up to January 2010.
Searching other resources
In an attempt to uncover any additional relevant published data,
grey literature, unpublished data, and research in progress, we:
• contacted authors of the identified articles and asked to identify
other published and unpublished randomised controlled trials (see
Table 1);
• searched the references of all included articles for further ran-
domised controlled trials;
• searched the UK’s National Research Register: https:// por-
tal.nihr.ac.uk/ Pages/ NRRArchive.aspx ;
• searched websites listing ongoing trials: http://clinicaltrials.gov/
, http:// www.controlled-trials.com/ and http://www.actr.org.au/.
Data collection and analysis
Selection of studies
The search strategy above was implemented by SM and JL
with support from Liz Arnold (trials search co-ordinator in the
Cochrane Airways Group) and references imported to Endnote
and duplicates deleted. SM and JL independently checked the ti-
tles and abstracts of potentially eligible studies. We obtained full
text copies of potentially relevant studies and SM and JL assessed
their eligibility for inclusion against the criteria outlined above.
Disagreements were resolved through discussion. We set out rea-
sons for exclusion in the Characteristics of excluded studies table.
Data extraction and management
Data were extracted by two independent reviewers (SM and UN)
from selected studies using a customised data extraction form. The
following data were extracted:
• country and setting;
• design (description of randomisation, blinding if possible,
number of study centres and location, number of study
withdrawals);
• participants (N, mean age, age range of the study gender
ratio, baseline lung function);
• system of telehealthcare being investigated, intervention
and control description (provider, material delivered, control
intervention (if any), duration, level of interactivity with
professionals);
• outcomes and definitions of outcomes used;
• proportion of participants with follow-up data;
• any harms or adverse effects;
• sources of funding.
Assessment of risk of bias in included studies
We assessed the quality of each trial following the Cochrane ap-
proach using the methods detailed in section six of the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2008).
We concentrated on the following parameters to assess quality:
1. Was the allocation sequence adequately generated?
2. Was allocation adequately concealed?
3. Was knowledge of the allocated intervention adequately
prevented during the study? (Blinding?)
4. Were incomplete outcome data adequately addressed?
5. Are reports of the study free of any suggestion of selective
outcome reporting?
6. Was the study apparently free of other problems that could
put it at a high risk of bias?
Each parameter was judged to be at high, low or unclear risk of
bias.
Measures of treatment effect
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Data were combined using Review Manager 5 software. We used
a fixed-effect standard mean difference for continuous data vari-
ables, such as scores from St Georges Respiratory Questionnaire
and Chronic Respiratory Questionnaire. We used a fixed-effect
odds ratio for dichotomous variables in the absence of significant
heterogeneity (I2< 40%; random-effects meta-analysis would have
been undertaken if the I2was > 40%). We aimed to conduct an
intention-to-treat analysis, i.e. including all those randomised to
their original groups, whether or not they remained in the study.
For the primary outcome of exacerbations we calculated a number
needed to treat to benefit (NNTB) for the different levels of risk,
as represented by the usual care group event rates over a specified
time period.
Unit of analysis issues
Odds ratios were used in calculations relating to dichotomous out-
comes such as patients with one or more exacerbations. Standard-
ised mean differences were used in relation to continuous out-
comes such as score value on the St Georges Respiratory Ques-
tionnaire.
Dealing with missing data
We would have reported and investigated missing data, where
possible. We would have contacted the study authors if necessary.
Assessment of heterogeneity
Statistical variation between the combined studies was measured
using the I2 statistic (Higgins 2008). If this had exceeded 40%
we would have investigated the potential causes of heterogeneity
through subgroup analyses.
Assessment of reporting biases
We would have used funnel plots and associated statistical models
to assess possible reporting bias, had there been a sufficiently large
number of studies in the meta-analysis for it to be meaningful.
This was not the case as our largest meta-analysis contained only
three studies.
Data synthesis
Data were synthesised into Forest plots and where possible a meta-
analysis performed to provide the best summary estimates.
Subgroup analysis and investigation of heterogeneity
Weplanned to analyse subgroups according to age, socioeconomic
status, ethnicity and type of intervention, had the data been avail-
able.
Sensitivity analysis
We planned to conduct sensitivity analysis on the basis of risk of
bias in studies and methods of data analysis (fixed- and random-
effects models).
R E S U L T S
Description of studies
See: Characteristics of included studies; Characteristics of
excluded studies; Characteristics of studies awaiting classification;
Characteristics of ongoing studies.
See Characteristics of included studies table for details of included
studies. The two largest studies which contributed to the results
of this review and which featured most heavily in the Forest plots,
i.e. Bourbeau 2003 and Casas 2006, both involved telehealthcare
as part of a complex intervention, of which telehealthcare was
only part, and so teasing out exactly which aspects of the com-
plex intervention were responsible for the results remains to be
done. In Bourbeau 2003, patients in the intervention group had
access to a complete COPD management programme with skills
taught by nursing and physiotherapy COPD case managers who
saw the patients at regular intervals face-to-face as well as conduct-
ing telephone follow-ups. Casas 2006 included an integrated care
intervention which was supported and co-ordinated by telecom-
munications. The patients saw case managers face-to-face for ed-
ucation before discharge, then following discharge co-ordination
of their care was enhanced by the use of a web-based tool and
the telephone. These are state-of-the-art integrated chronic illness
care plans and the contribution of telecommunications per se is
very difficult to determine. It remains uncertain whether any im-
provements are due to the nature of the complex intervention re-
gardless of the nature of the technology used to deliver it. The
Nguyen 2008 study was the only one which appears to address
the telecommunications technologies as independent factors.
Results of the search
We identified 10 randomised controlled trials reported in 12 pa-
pers which satisfied the inclusion criteria, involving 1004 pa-
tients (Bourbeau 2003; Casas 2006; Garcia-Aymerich 2007;
Chandler 1990; de Toledo 2006; Finkelstein 2004; Finkelstein
2006; Johnston 2000; Nguyen 2008; Vitacca 2009; Whitten
2007; Wong 2005; see Figure 1). Finkelstein 2004 was related to
the Finkelstein 2006 paper in that the latter had an extra outcome
measure but was the same study. Casas 2006 was an extended re-
porting of the Garcia-Aymerich 2007 paper including extra data.
. Of the 1004 participants involved, the vast majority had COPD
except for in two studies. Where these studies did not specify the
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exact number of patients with COPD we wrote to the authors to
request clarification. Authors who responded are acknowledged in
Table 1.
Figure 1.
Included studies
The participants, interventions and outcomes are listed in the
Characteristics of included studies table. Three studies (Bourbeau
2003; Chandler 1990; Wong 2005) used the telephone system.
Casas 2006/Garcia-Aymerich 2007; Nguyen 2008; Vitacca 2009
used the Internet. de Toledo 2006 used a specialist indepen-
dent network with video and Johnston 2000; Finkelstein 2004/
Finkelstein 2006;and Whitten 2007 used videoconferencing. Of
the videoconferencing studies, Finkelstein 2004/Finkelstein 2006
also used other physiological telemonitoring systems alongside the
videoconferencing. We found details of 21 ongoing or unpub-
lished trials: these are listed in the description of ongoing studies
and description of studies awaiting classification.
Excluded studies
We excluded studies if they were not randomised controlled trials
and if they were not COPD-focused or did not fit our inclusion
criteria. These studies are listed in the Characteristics of excluded
studies table.
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Risk of bias in included studies
Allocation
Three of the studies were randomised using computer generated
random numbers (Nguyen 2008; Vitacca 2009; Wong 2005),
and a further six stated that they were randomised but did
not describe the method (Bourbeau 2003; Chandler 1990; de
Toledo 2006; Finkelstein 2004/Finkelstein 2006; Johnston 2000;
Whitten 2007). The Casas 2006/Garcia-Aymerich 2007 study
used a 2:1 randomisation ratio during the first three months of
the study at its Barcelona site. The effect of this difference is to
make interpretation more difficult.
Blinding
It was not possible to blind the patients to treatment allocation
due to the interactive nature of the intervention. However, some
attempt to blind outcome assessors to the participants’ allocation
was made in Bourbeau 2003 and Chandler 1990. None of the
other studies blinded outcome assessors or data analysers.
Incomplete outcome data
Incomplete outcome data was a feature in the following trials: in
Casas 2006/ Garcia-Aymerich 2007 only 57% of patients finished
the intervention arm at 12 months and so an intention-to-treat
analysis could not be performed. In Finkelstein 2006, a reduced
number of patients finished the study protocol.Whitten 2007 had
a problemwith turnover of study nurses and nurses being reluctant
to record study data and so complete data were only available
for 37 intervention patients and 30 in the control group. In the
Wong 2005 study, data for missing patients were replaced with
the mean of the other participants’ scores: this is not necessarily a
valid method to replace data.
Selective reporting
Chandler 1990 did not report on several outcomes. Finkelstein
2004 selected which outcomes on which to report thus potentially
biasing the reader to anticipate positive information. Themajority
of papers reported according to their methods section. No proto-
cols were sought with which to compare the results sections.
Other potential sources of bias
There was a risk of selection bias in Bourbeau 2003. Casas 2006/
Garcia-Aymerich 2007 did not have other sources of bias. Partic-
ipation bias was a risk in de Toledo 2006 as people in the inter-
vention arm may have felt better cared for. In Finkelstein 2004/
Finkelstein 2006 the early reporting of favourable outcomes was
probably the most important source of bias. Interventions were
made in both groups in the Nguyen 2008, i.e. one group was in-
troduced to an electronic dyspnoea management program and one
group was introduced to a face-to-face programme. This brings
the validity of this face-to-face programme as a control into ques-
tion because it is also a change to the normal procedure of care
and so could be considered to be an intervention - albeit a non-
telehealthcare intervention. Whitten 2007 and Wong 2005 were
free of other apparent biases.
Effects of interventions
Primary outcomes
Total exacerbations
The only study to record the total number of exacerbations as
a separate figure was the Bourbeau 2003 study. Bourbeau 2003
reported 362 acute exacerbations of COPD in the control group
(N = 95) and 299 exacerbations in the intervention group (N =
96) over a 12 month period. The difference was of borderline
statistical significance; P = 0.06.
Vitacca 2009 reported that the mean number of exacerbations per
month was significantly higher in controls than in the telehealth-
care group (0.78±0.77 and 0.23±0.38, respectively; p<0.0001).
Time free from exacerbation days was reported as a Kaplan-Meier
chart: in the intervention group 30% of patients (17/57) were free
of an exacerbation at one year while in the control group only 5%
of patients (2/44) were free of an exacerbation at one year.
Quality of life
Bourbeau 2003 and Casas 2006/Garcia-Aymerich 2007 reported
health related quality of life scores using the validated St George
Respiratory Questionnaire (SRGQ). This scale goes from 0 (better
health) to 100 (worse health). Negative change means improve-
ment, the minimal clinically significant difference in health status
is a change in score by 4 points (Hajiro 2002). The meta-analysis
by random-effects generated a mean difference of -6.57 (95% con-
fidence interval (CI) -13.62 to 0.48), that is a minimally clinically
significant change although the confidence intervals are very wide
(see Figure 2).
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Figure 2. Forest plot of comparison: 1 Quality of Life, outcome: 1.1 Quality of Life over 12 months.
Nguyen 2008 compared face-to-face dyspnoea management for
COPD patients with a dyspnoea management program delivered
via an electronic web-networked interface. The validated Chronic
Respiratory Questionnaire, the CRQ, was used to assess health
related quality of life. The minimal clinically important difference
is 0.5 (Hajiro 2002).
A meta-analysis combining CRQ and SRGQ score should not be
used as Puhan 2006 has shown that the CRQ is a much more
responsive tool than the SRGQ.
Emergency department visits
A meta-analysis of the three studies (Bourbeau 2003; de Toledo
2006;Vitacca 2009) which reported data on emergency depart-
ment visits during their 12 months was performed by random-ef-
fects (see Figure 3). This showed that patients with telehealthcare
were much less likely to attend the emergency department than
patients in the control group: OR 0.27 (95% CI 0.11 to 0.66).
Figure 3. Forest plot of comparison: 2 Emergency Dept Visits, outcome: 2.1 Number of patients with one
or more emergency dept attendance over 12 months.
One patient was sent to the emergency department in the Nguyen
2008 study, an insignificant result. Wong 2005 recorded the av-
erage number of visits per patient over a three month period as
greater in the control group, OR 0.17 (95% CI 0.04 to 0.67). In
contrast to these findings, Johnston 2000 reported that the average
number of visits per patient was 1.79 (SD 1.48) for intervention
patients and only 1.53 (SD 1.43) for control patients. No other
studies reported on emergency department visits.
Hospitalisations
The following studies produced data on hospitalisation: Bourbeau
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2003; de Toledo 2006; Casas 2006; Vitacca 2009. In order to pool
all four trials the variable for number of patients with one or more
hospital admissions during the 12 month period was entered into
the Analysis 3.1. This generated an odds ratio of 0.46 (95% CI
0.33 to 0.65); P < 0.00001, see Figure 4.
Figure 4. Forest plot of comparison: 3 Hospitalisations, outcome: 3.2 No. of patients with one or more
hospitalisations in 12 months.
Finkelstein 2006 reported on the outcome measure of discharge
to a higher level of care, either hospital or a nursing home, see
Analysis 3.2; OR 0.29 (95% CI 0.08 to 1.05), i.e. telehealthcare
patients have a lower odds of being discharged to a higher level of
care than usual care patients.
Wong 2005 reported that there was no significant difference be-
tween the telephone and the control group in hospitalisation rates
at three months: P = 0.182.
Deaths
Four studies (Bourbeau 2003; Casas 2006; de Toledo 2006;
Vitacca 2009) reported the number of deaths in each arm over the
course of the 12 month study and so three of these were combined
using the fixed-effect model. Vitacca 2009 included data from pa-
tients who did not have COPD, however, when stratified for diag-
nosis mortality rate these did not differ between the intervention
and control groups. Analysis 4.1 resulted in an odds ratio of 1.05
(95% CI 0.63 to 1.75) but this was non-significant with P = 0.86;
see Figure 5.
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Figure 5. Forest plot of comparison: 1 Deaths over 12 months, outcome: 1.1 Deaths over 12 months.
In Finkelstein 2006, patients with congestive heart failure or
COPDwere allocated to either traditional skilled nursing at home
- the control group, or a video intervention involving virtual visits
with videoconferencing technology, or a physiological monitoring
group, including pulse oximetry, electronic spirometers and auto-
matic blood pressure cuffs and virtual visits. There was no statisti-
cally significant difference in mortality between the three groups:
(26.3% of control, 20.6% in the virtual and monitoring groups; P
= 0.74). These figures are treated separately in Analysis 4.2 because
the congestive heart failure patients cannot be separated from the
COPD patients and the data are collected for six months only.
There were no further deaths in any of the other studies.
Secondary outcomes
Forced Expiratory Volume in 1 minute in litres (FEV1)
In Bourbeau 2003 lung function did not change significantly from
baseline to the end of the study. Mean ± SD at baseline was 0.98
± 0.31 in the usual care group and 1.01 ± 0.36 at 12 months. In
the intervention group, baseline FEV1 was 1.0 ± 0.33 and 0.96 ±
3.2 at 12 months.
Casas 2006/Garcia-Aymerich 2007 reported mean change ± SD
in FEV1 of 0.06 ± 0.35 in the usual care group and 0.01 ± 0.14
in the intervention group, i.e. the usual care group increased by
more but not by a statistically significant difference, P = 0.6.
Forced Vital Capacity in litres (FVC)
In Bourbeau 2003 FVC mean ± SD was 2.24 ±0.69 at baseline
and 2.3 ± 0.68 at 12 months in the control group and 2.27 ±
0.74 at baseline and 2.31 ± 0.77 at 12 months in the intervention
group. These differences were not significant.
Patient satisfaction
Three studies reported on patient satisfaction using different and
unvalidated scales and so their results are difficult to interpret.
Johnston 2000 reported that overallmore than95%of both groups
agreed or strongly agreed with the following statements pertinent
to in-person visits:
1. appreciated having health provider visit home;
2. confidence in provider’s ability to assess health condition
during home health condition during home health care in-
person visits;
3. comfortable discussing personal problems or concerns with
provider during home health care in-person visits;
4. received appropriate level of personal care and attention
from provider during home health care in-person visits.
All between group differences were statistically non-significant.
With respect to the survey of the intervention group’s satisfaction
with remote video visits, again over 90% of the group agreed or
strongly agreed with the following statements:
1. appreciated having remote video visit system in my home;
2. confident in provider’s ability to assess health condition by
using remote video visit system;
3. comfortable discussing personal problems with my provider
by using remote video visit system;
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4. received appropriate level of personal care and attention
from my provider when using remote video visit system;
5. remote video visits were convenient for me;
6. remote video visits allowed timely access to provider.
Nguyen 2008 reported satisfaction with dyspnoea self-manage-
ment programme according to a 3 point scale where 1 = not at
all satisfied, 2 = quite satisfied and 3 = very satisfied. Satisfaction
scores for both programmes were similar: 2.7 ± 0.47 for the face-
to-face overall program and 2.6 ± 0.51 for the telehealthcare pro-
gramme.
Whitten 2007 conducted interviews with 49 patients using Likert
scales from 1 = strongly disagree to 5 = strongly agree with the
following statements:
1. I found the home telehealth equipment easy to use;
2. I think telehealth is a good way to provide home health care
for patients with heart/lung disease;
3. I think home telehealth is a good way to provide
educational information on COPD/CHF management;
4. it was easy to communicate with the other person during
the home telehealth consultation;
5. the care that I received via the home telehealth visit was as
good as a regular in-person visit;
6. I would rather be seen in person than over the home
telehealth equipment;
7. home telehealth should only be used when a healthcare
professional cannot be physically present;
8. overall, I am satisfied with the home telehealth service that I
received.
Patientswere in agreementwith all of these statements.Overall this
suggeststhat the patients were very satisfied with the telehealthcare
programmes.
Study withdrawal
Details of study withdrawals are reported in the Risk of Bias tables
in the ’Incomplete outcome data’ section.
Costs
Three studies (de Toledo 2006; Finkelstein 2006; Johnston 2000)
reported costs relevant to their studies. Here they are presented in
US dollars (USD) as converted in June 2010.
de Toledo 2006 compared the costs of their clinical experiment of
EUR 38,932, USD 47,849, with the cost of one day’s admission
for COPD, EUR 220, USD 270.34 a day. They calculated that
the reduction of hospitalisation days would pay for the system
before the end of the first year (mean duration of hospitalisation
2.8 days, no. of patients = 157).
Finkelstein 2006 calculated that the cost per visit of an actual
visit by a nurse was USD 48.27 primarily due to the amount of
additional nursing time required to conduct an actual visit and
related travel costs. The cost of a virtual visit only was USD 22.11
per visit. The cost of a virtual visit with monitoring was USD
33.11 per visit.
Johnston 2000 found that outpatient costs for the two groups did
not vary by much. However, hospital costs per patient were much
greater for patients in the control group than for patients in the
intervention group and that the total mean cost per patient in
the control group was USD 2674 (SD = USD 6313) and in the
intervention group was USD 1948 (SD =USD3681). These large
standard deviation figures mean that caution should be exercised
when generalising from these results.
Bourbeau 2006 was a follow-on paper reporting economic bene-
fits of the Bourbeau 2003 study. Total per-patient cost of the self-
management intervention was USD 3778, mostly accounted for
by the case manager’s salary (USD 3338). In the study each case
manager supervised 14 patients and there was no significant dif-
ference in costs between the experimental and control groups.
Cost effectiveness
Bourbeau 2006 calculated cost effectiveness as USD4214 per hos-
pitalisation prevented with a caseload of 14 patients per case man-
ager. With assumed increasing caseloads of 30, 50 and 70 patients
per case manager the estimated incremental cost-effectiveness ra-
tios were USD 2053, USD 1326 and USD 1016 per hospitalisa-
tion prevented, respectively.
D I S C U S S I O N
Summary of main results
Published research suggests that telehealthcare has the capacity to
reduce exacerbations and may improve the quality of life of the
people using it in comparison to usual care. Emergency depart-
ment visits are significantly reduced, as are hospital admissions in
COPDpatients, without clearly increasing morbidity or incurring
excessive costs.
Overall completeness and applicability of
evidence
These results seem to be very encouraging for the supporters of
telehealthcare. There are clear advantages to patients and health-
care systems in the studies fromwhich we were able to pool results:
emergency department visits and hospital admission rates are re-
duced with minimal impact on mortality, morbidity and quality
of life. This leaves considerable scope for cost savings and there is
some evidence for this from the studies which have studied cost
as an outcome.
One limitation of the evidence is whether or not it was valid to per-
form meta-analysis with this type of complex intervention. Tele-
healthcare may be regarded as a complex healthcare intervention,
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as defined by the MRC framework for design and evaluation of
complex interventions. The most extensive forest plot in this re-
view contains only four studies. If we look more closely at these
studies we find that we have not necessarily been comparing like
with like and so the validity of any conclusion drawn from these
figures must be interpreted with caution. Bourbeau 2003, Casas
2006 and de Toledo 2006 together seem to support the conclu-
sion that telehealthcare does not increase deaths. However, Casas
2006 intervention was a form of post-discharge integrated sup-
port involving multiple ingredients. Breathing exercises, physical
exercises, education, psychological support, specialist nursing and
other elements were all built into an individual care plan. Tele-
healthcare came in only after the patient was discharged to main-
tain access to these ingredients via a web-based communication
device. Bourbeau 2003 had even less emphasis on telehealthcare,
in this case the intervention was delivered through the medium of
home visits over a two month period and the telephone was only
used for follow-up. de Toledo 2006 has perhaps the most reliance
on technology, but again the telehealthcare is only the delivery
mechanism for an enhanced package of integrated chronic illness
care.
It may indeed be valid criticism of this study to say that the im-
proved outcomes demonstrated were entirely due to the provision
of these integrated care programmes and the fact that the pro-
grammes were delivered from a distance by telehealthcare is en-
tirely irrelevant. The answer to this is “maybe”, we don’t know
for sure yet due to the design of the trials available. The small
Nguyen 2008 study was probably the closest design to answering
this as the dyspnoea management programme was made available
to one arm by means of face-to-face interaction and to the other
by Internet. Unfortunately, this study stopped early due to multi-
ple technical challenges, at this stage the authors reported positive
improvements in both arms of the study with no significant dif-
ferences with respect to program modality. However, the study is
small with a significant withdrawal rate and can be criticised for
not having an additional usual care arm - otherwise how are we to
know that there was not simply a seasonal or other improvement
across both arms within the study?
The ingredient which telehealthcare has the potential to offer that
does not come from other forms of integrated programme is that
of “access”, improving the access to the programme’s effective ele-
ments, be that education, other advice, verbal or written support,
or potentially monitoring for reassurance. This concept of access
could be better defined for future research. It may be that elements
of current COPD care are already effective, they just need to be
made more accessible.
If we return to the list adapted from Finkelstein of themechanisms
through which telehealthcare appears to mediate its success:
1. providing patient education and counselling for primary
prevention and early detection of disease;
2. improving adherence to medications and other treatment
regimens;
3. collecting patient data remotely;
4. replacing face-to-face nursing/physician visits;
5. providing early detection of incipient disease exacerbation
and timely intervention for early symptom management;
6. reducing unscheduled/unnecessary visits to the physician
and emergency room;
7. preventing repeat hospitalisations;
it can be seen that the idea of access is central to many of these
mechanisms.
In order to apply telehealthcare successfully in the future, stud-
ies need to be carefully designed so as to consider the “access” as
enabled by the telehealthcare. This will avoid the benefits of tele-
healthcare being lost in studies which cover new programmes of
healthcare that introduce multiple elements only one of which is
the fact that care can be delivered from a distance.
Also, in terms of the applicability of the evidence we need to
consider the fact that several studies failed due to technological
challenges. This was not only unreliability of the technology but
difficulties of an older pre-technological population struggling to
use these systems. It is exactly this vulnerable population that we
wish to target in terms of preventing increasing admissions to
hospital with increasing morbidity, as they enter the severe “end-
stage” of their COPD trajectory (Murray 2006).
Quality of the evidence
The evidence is very heterogeneous, particularly in terms of its
definition of COPD - some patients were recruited on discharge
from hospital, but not all. The interventions are heterogeneous -
not only in terms of the technology employed, whether telephone,
video or Internet but in terms of the ingredients within the inter-
vention. These would be better understood as “complex interven-
tions”. In fact it can be seen that, in terms of the MRC’s frame-
work for complex health interventions, phase 0 (theoretical work)
and phase 1 (modelling how the intervention works) of the clini-
cal trial agenda have been bypassed and researchers have launched
into phase 2 (exploratory or pilot trials) and phase 3 (definitive
randomised controlled trials), without sufficient preparation. The
result of this is that the trials are not adequately designed to ad-
dress sufficiently and specifically the question of the “access” in-
gredient because so many other factors are liable to influence the
results of the experiments. In addition, the technical challenges
from what is now regarded as old technology have resulted in a
body of evidence of only moderate quality. In the future, further
qualitative research will help to characterise what is valued about
access and what is practicable within that. This would then set a
basis for quantitative research looking at hospital admission, mor-
bidity, mortality and cost-effectiveness. The quantitative research
would be designed along the lines of the Nygugen study in which
the two arms of the trial differed only in the nature of the method
of delivery of the intervention, i.e. telehealthcare versus standard,
and not in the content of the intervention. The content of the
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intervention delivered would have to be current state-of-the-art
practice in terms of its clinical elements.
Potential biases in the review process
This review process should have minimum bias. We used a very
broad search strategy in conjunction with The Cochrane Library
in order to capture as many studies as possible. This methodol-
ogy means that both completed and ongoing randomised con-
trolled trials coded as COPD by the Cochrane Airways Group
were searched for a broad range of telehealthcare terms. Two au-
thors then independently chose relevant articles from this list and
met to discuss a final list of included studies. Although all the trials
included were published in English we would have been prepared
to translate and include relevant trials in other languages, thereby
helping to minimise bias.
Agreements and disagreements with other
studies or reviews
Polisena 2010 is the only other systematic review of telehealthcare
in COPD that we have come across. We agree with its findings
that telehealthcare, whether home telemonitoring or telephone
support, reduces rates of hospitalisation and emergency depart-
ment visits. Unfortunately, their result showing an increase in the
mortality due to telehealthcare appears to be due to a transposition
of the results of the Borbeau study between the intervention and
control groups. We have informed the authors of this. Polisena
2010 included a number of studies in which we considered that
themain intervention did not fall into our definition of telehealth-
care and its inclusion criteria were not limited to randomised con-
trolled trials. This can introduce bias as about half of their studies
were observational rather than randomised.
There are an extensive number of other studies ongoing or which
have only reported in abstract form so far. It will be necessary to
update this review over the next two years as these projects come
to fruition.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Overall, only a small evidence base has been uncovered to support
the use of telehealthcare inCOPD.However,medicalmanufactur-
ers and policy makers are keen to introduce this technology widely
due to a very optimistic view of its potential. We would advocate
caution in this endeavour as our research shows that substantial
aspects of the technology are inconclusive - for example, its impact
on quality of life. The limited evidence available suggests that tele-
healthcare does not significantly increase nor decrease mortality
in COPD patients, but the confidence intervals are too wide to
conclude that there is no impact on mortality.
Implications for research
Most telehealthcare interventions for COPD have been intro-
duced as part of a complex package of enhanced care. In future,
research studies need to build up an increased body of qualitative
work which will help to determine the precise contribution of tele-
healthcare to the package. A theoretical framework for telehealth-
care will help to establish a consistent intervention. Detailed de-
scription of the precise nature of the intervention when reporting
studies will help when comparing interventions. Separate classifi-
cation of the form and then the function of the telehealthcare; e.g.
videoconferencing (form) to keep people out of hospital (function)
is required. In this way, different technologies may be compared
where their function is the same - drawing again from Finkelstein’s
mechanisms. An alternative to videoconferencing to treat an exac-
erbation and thereby avoid hospital admission, might be the use
of an Internet package with oxygen saturation telemonitoring or
remote spirometry with a telephone component, i.e. same func-
tion, different forms of intervention. This kind of theoretically
based study will go further in telling us which functions of tele-
healthcare are most successful with which forms of delivery. These
classified interventions should then be compared in larger trials
with longer durations. In addition, more detail should be obtained
regarding the outcomes of the studies so that precise comparisons
may be made as to the relative advantage of telehealthcare over
other types of intervention. Similarly, studies which stratify the
COPD patients by their severity might find that a specific sub-
group of patients stand to gain greatest independence from their
illness through the use of telehealthcare technologies.
The deployment of telehealthcare for COPD iswidely anticipated,
however, more detailed research is needed in order to realise its
potential fully.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Bourbeau 2003
Methods A multicentre randomised clinical trial
Participants 191 patients were randomised. All patients in each participating hospital, of 3 inQuebec,
who had been hospitalised for at least once in the preceding year for an acute exacerbation
of COPD were screened for participation. The eligibility criteria included: be a current
or previous smoker with FEV1 after bronchodilator between 25% and 70% of predicted
normal value; have no evidence of asthma, left congestive heart failure, terminal disease,
dementia or uncontrolled psychiatric illness
Interventions Intervention: The intervention group received a COPD self management program, con-
sisting of 1 hour a week teaching at home for 7 to 8 weeks, in English or French. Super-
vised by experienced nurses or respiratory therapists who acted as case managers. Follow-
up consisted of weekly telephone calls for 8 weeks during the educational period then
monthly calls for the remainder of the study. The patients could also contact their case
manager for advice during this time
Control: Both groups continued their usual care by their respective general practitioners
and specialists and there was no restriction on their access to the regional universal health
program
Outcomes 1. Medication profile.
2. Spirometry.,
3. 6 minute walk test.
4. Dyspnoea measurements after exercise.
5. Health related quality of life as measured by the St George Respiratory Questionnaire
(SGRQ)
6. Healthcare utilisation.
7. Costs.
8. Cost effectiveness.
Notes There were 469 eligible patients; however, 251 refused to participate and 27 who agreed
to participate were deemed to live too far away thus 191 patients were randomised. This
level of exclusion risks introducing selection bias especially as certain socioeconomic
groups are perhaps more likely to refuse to participate in studies. However, the authors
do state that those who refused were similar to the study group with respect to sex, age
and level of airflow obstruction
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated list of random numbers
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Bourbeau 2003 (Continued)
Allocation concealment (selection bias) Low risk “randomisation with the use of a central com-
puter generated list of random numbers”,
“The blocking factor was not known by the
investigators or their staff in each participating
centre
Blinding (performance bias and detection
bias)
All outcomes
Low risk “As a double blind design was impossible, an
independent evaluator unaware of the patient
assignment was responsible for the evaluation
process in each centre. The evaluator was cau-
tioned not to ask about the workbook mod-
ules and types of contact”
Incomplete outcome data (attrition bias)
All outcomes
Low risk 26 patients dropped out after randomisation,
1 was lost to follow up and 11 found that the
burden of evaluationwas too great. 14 patients
in total died
Selective reporting (reporting bias) Low risk No evidence of selective reporting
Other bias High risk Possible selection bias
Casas 2006
Methods Randomised controlled trial.
Participants Patients: Conducted in Barcelona (Spain) and Leuven (Belgium), 155 COPD patients
were recruited from two tertiary hospitals immediately following hospital discharge. All
patients had been previously admitted for a COPD exacerbation for more than 48 hours
Interventions Intervention: Awell-defined integrated care interventionwith the support of information
and communication technologies. This was standardised across the two centres and
included physical and social assessment, education and co-ordination by a case manager
between hospital and primary care teams. Co-ordination was facilitated by a web-based
call centre. Weekly phone calls during the first month after discharge helped to embed
the lessons learnt during the education sessions
Control: Both groups continued their usual care by their respective general practitioners
and specialists and there was no restriction on their access to the regional universal health
program
Outcomes 1. Hospital re-admission.
2. Quality of life was assessed by St George Respiratory questionnaire
3. Clinical features.
4. Co-morbid conditions.
5. Healthcare utilisation.
Notes Only 19% of the 850 patients screened were deemed appropriate for randomisation
following the application of the inclusion criteria
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Casas 2006 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk All patients were blindly assigned (1:1 ratio) using com-
puter generated random numbers to either intervention
or control. A different randomisation ratio was used in
one of the centres (Barcelona 1:2 ratio) during part of
the study, resulting in the arms having different numbers
of patients (65 intervention, 90 control)
Allocation concealment (selection bias) Unclear risk Insufficient evidence
Blinding (performance bias and detection
bias)
All outcomes
High risk Impossible to blind from intervention, no evidence of
blinding outcome assessors
Incomplete outcome data (attrition bias)
All outcomes
Low risk After randomisation a total of 4 patients moved on to
palliative care, there were 26 deaths, 2 new neoplasms
and 3 changes of address, and so 35 patients were ex-
cluded from the trial. Of 155, 30% excluded
Selective reporting (reporting bias) Unclear risk Data reported across two papers, Garcia paper does not
make clear that it is part of a larger trial
Other bias High risk Risk of selection bias as only 19% of the 850 patients
screened were deemed appropriate for randomisation
following the application of the inclusion criteria
Chandler 1990
Methods This was a randomised pilot clinical investigation.
Participants 13 adult patients with COPD, asthma or both who were receiving theophylline from an
outpatient department of pulmonary medicine, Kentucky, United States of America
Interventions The intervention group was taught how to measure their theophylline level at home
using a specialised instrument which only required a small blood sample obtained by
fingerstick and then they phoned the clinic for advice on drug dosage
Control: The control group attended the clinic for traditional therapeutic drug moni-
toring, i.e. blood testing and advice face-to-face. This continued for 6 months
Outcomes 1. Pulmonary function testing with an electronic spirometer at each clinic visit
2. Patients were evaluated for degree of dyspnoea at each clinic visit using the baseline
dyspnoea index and the transitional dyspnoea index
3. Visual analogue scales for night time cough and daytime cough, wheezing and breath-
lessness were completed once a month
4. Questionnaires on adverse effects were also completed once a month, addressing nau-
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Chandler 1990 (Continued)
sea, vomiting, diarrhoea, nervousness, headache, tremor, sleeplessness and heart palpita-
tions
5. Patients; health attitudes and beliefs were measured using the Krantz Health Opinion
Survey and the Multidimensional Health Locus of Control to measure patient attitudes
towards different healthcare approaches and the degree to which individuals believed
their health to be affected by internal or external factors, respectively
Notes The major risk of bias in this study came from the fact that just 13 patients were
recruited and only 11 patients finished the study: constituting a very small study group.
In addition, only eight of the patients had COPD, the rest had asthma. Also, there were
4 male patients and 7 female patients. With these shortcomings in mind, it is unlikely
that results from this study can be generalised despite the authors careful attempts to
randomise and blind the participants appropriately
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “patients were assigned by a random num-
bers table into one of two treatment
groups”
Allocation concealment (selection bias) Unclear risk Insufficient information
Blinding (performance bias and detection
bias)
All outcomes
Low risk “Spirograms were administered by a res-
piratory therapist blinded to treatment
group”; “each patient was interviewed by a
blinded investigator who did not know the
group assignments or results of pulmonary
function tests.” Although the patient was
clearly not blinded from the intervention
Incomplete outcome data (attrition bias)
All outcomes
High risk Only 11 patients completed the study, 2
patients were lost to follow up
Selective reporting (reporting bias) High risk Several outcome measures not fully re-
ported, no reason given as to why not,
potentially because the difference across
groups was not significant
Other bias High risk Only 8 patients with COPD were re-
cruited, too small a sample for meaningful
generalisation
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de Toledo 2006
Methods Randomised controlled trial
Participants 157 COPD patients recruited during a tertiary hospital admission for an acute episode,
randomised to an intervention group: N = 67; age = 71 ± 8 years, 2.3 % women and
control group: N = 90; age = 72 ± 9, 3.2% women
Interventions The care team shared a web-based patient record which also featured mobile home visits
units and fixed home units. There was also integrated support for education (of both
professionals and patients) and videoconferencing with the patients. The intervention
group patients also had 24 hour access to the multidisciplinary care team via a call centre.
The call centre was not intended for dealing with emergency calls and stored out-of-
hours calls until the next day
Control patients did not have access to the call centre but received education and home
visits as well. Follow-up for these patients was made without the mobile home visit unit
and web-based patient management module
Outcomes 1. Number of readmissions.
2. Number of visits to emergency department.
3. Mortality.
4. Acceptability to professionals.
5. Patterns of use and equipment and communication costs.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “randomly distributed in an intervention and a control
group”
Allocation concealment (selection bias) Unclear risk Insufficient information
Blinding (performance bias and detection
bias)
All outcomes
High risk Impossible to blind patients to intervention, no evidence
of outcome assessor or data analyser blinding
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Insufficient information, no details of patients withdraw-
ing or lost to follow up
Selective reporting (reporting bias) Low risk No evidence of selective reporting, all outcomes in meth-
ods are reported
Other bias High risk Patients in the intervention group may have experienced
a feeling of being better cared for that may have improved
their outcomes. Extreme sex ratio in study groups may
limit generalisability
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Finkelstein 2004
Methods Randomised controlled trial
Participants This study included patients with a mix of conditions: Congestive heart failure, chronic
obstructive pulmonary disease and chronic wound-care patients. 68 subjects were en-
rolled, there was a requirement that either the subject or a supportive care partner was
able to physically and cognitively use the equipment within the home environment
Interventions Intervention: there were two intervention groups for this study. Firstly, standard care plus
videoconferencing/Internet access and, secondly, standard care plus videoconferencing
plus physiological monitoring, e.g. spirometry in COPD. These technologies allowed
Virtual Visits to be conducted between the nurse at the central site and the subject at
home with audio and video interactions. Patients were trained to use the equipment
Control: the control group received standard home health care
Outcomes 1. Termination from home care or loss of eligibility for home care
2. Time to discharge to a higher level of care such as a nursing home or hospital
3. Mortality.
4. Morbidity.
5. Patient perception of telehealthcare (Telemedicine Perception Questionnaire TMPQ)
6. Patient satisfaction Home Care Client Satisfact Instrument (HCCSI)
7. Quality and clinical usefulness of virtual visits.
8. Patient utilisation of services.
9. Cost for both subjects and service providers.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient data
Allocation concealment (selection bias) Unclear risk Insufficient data
Blinding (performance bias and detection
bias)
All outcomes
High risk Impossible to blind participants to intervention, not
statedwhether outcome assessorwas blinded or data anal-
yser
Incomplete outcome data (attrition bias)
All outcomes
High risk Out of 68 patients randomised 53 completed the study.
47 patients were interviewed after they concluded the
study to gather patient satisfaction data
Selective reporting (reporting bias) High risk There is a significant amount of data missing from this
report including costs and clinical effectiveness. Publish-
ing this favourable report on patient opinions may con-
dition the reader to expect further favourable results. The
authors state that the reason for not yet publishing hard
clinical endpoint cost data is that the data were not yet
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Finkelstein 2004 (Continued)
available
Other bias High risk Results for COPD cannot be separated from results for
other conditions and so this limits interpretation
Finkelstein 2006
Methods Patients, Intervention, Control, Outcome are the same as the 2004 study
Participants Same as for 2004
Interventions Same as 2004
Outcomes As 2004 plus this study reports the additional outcomes of discharge to a higher level of
care, i.e. hospital or nursing home, mortality, morbidity as evaluated by changes in the
knowledge behaviour and status scales of the Omaha assessment tool and data on costs
Notes Control: same as for 2004
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk See 2004 report
Allocation concealment (selection bias) Unclear risk See 2004 report
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk See 2004 report
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Only 53 subjects completed the study out
of the 68 enrolled.
Selective reporting (reporting bias) High risk The age distributions in all three groups
were similar. For several of the statistical
analyses the virtual visit group and the
monitoring group were combined into a
single intervention group. This influences
the results generated
Other bias Unclear risk Insufficient data
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Garcia-Aymerich 2007
Methods This study is a duplicate report of the Barcelona part of the Casas paper above. This
may introduce selective reporting bias as it is not clear why the Belgian results are not
reported in this paper
Participants
Interventions
Outcomes
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk See Casas paper
Johnston 2000
Methods “quasi experimental”, “randomly assigned to an intervention or control group”, not clear
why this is not described as a randomised controlled trial
Participants Newly referred patients with COPD, congestive heart failure, cerebral vascular accident,
cancer, diabetes, anxiety or need for wound care were randomly assigned to intervention
(N = 102) or control (N = 110). The patients all had a projected need for two or more
visits a week. The study took place in Sacramento California through a large health
maintenance insurance organisation. 29 intervention grouppatients and19of the control
group had COPD
Interventions Intervention: Both groups received routine home health care with visits and access to
telephone contact. However, the study group also used a remote video system allowing
nurses and patients to undertake virtual visits in real time any time during 24 hours a
day. There was also equipment attached to the video for testing cardiopulmonary status
Control: Controls used routine healthcare with home care visits but without a video
system. They also had access to telephone advice and triage
Outcomes 1. Use of services.
2. Costs for inpatient and outpatient services.
3. Visits to emergency departments.
4. Costs for pharmacy services, laboratory, physician, emergency department visits, in-
patient treatment, home healthcare costs and videoconferencing costs
5. Patients’ compliance with medication regimen.
6. Patients’ knowledge about their disease.
7. Patients’ ability to move towards self care.
8. Patient satisfaction survey.
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Johnston 2000 (Continued)
Notes Results and interventions for COPD patients are not presented separately from other
illnesses
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “quasi experimental”, “randomly assigned
to an intervention or control group”
Allocation concealment (selection bias) Unclear risk Insufficient information
Blinding (performance bias and detection
bias)
All outcomes
High risk No blinding
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Insufficient information
Selective reporting (reporting bias) High risk Total costs of items are reported rather than
absolute numbers of emergency dept visits
etc. However, this is in accordance to the
methods implied reporting
Other bias High risk Funded by Kaiser Permanente and so only
collected data from plan members which
may rule out balance of sociodemographic
groups. COPD patients are not measured
or analysed separately and so some data are
of limited use
Nguyen 2008
Methods A randomised controlled trial.
Participants Patients: 50 patients with moderate to severe COPD who were current Internet users
were assigned to one of two dyspnoea management intervention programs, in California
or Seattle. Patients were recruited fromweb and non-web sources, including distribution
lists, chest clinic referrals, and support groups both real and digital
Interventions Intervention:The Internet based dyspnoeamanagement intervention program (eDSMP)
focused on education, skills training and ongoing support for dyspnoea self management
and was delivered via a personal digital assistant or Internet
Control: The face to face dyspnoea management intervention program (fDSMP) deliv-
ered the same content via education sessions, reinforcement contacts and peer interac-
tions: all face to face
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Nguyen 2008 (Continued)
Outcomes Evaluations were performed at 3 and 6 months.
1.Dyspnoeawith activities of daily living,and quality of life asmeasuredwith theChronic
Respiratory Questionnaire
2. Exercise behaviour exercise performance.
3. COPD exacerbations were also measured.
4. Self-efficacy and social support were measured as mediators
5. At the final visit a satisfaction survey and a semi-structured interview were performed
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “an investigator who was not involved in the day-to-
day study operations generated the randomisation se-
quence using the SPSS version 14.0 random sequence
generator feature”
Allocation concealment (selection bias) Low risk “separate sealed opaque envelopes.”
Blinding (performance bias and detection
bias)
All outcomes
High risk Unable to blind study nurse to treatment assignment
Incomplete outcome data (attrition bias)
All outcomes
High risk Of 50 patients randomised, 39 remained after 6
months. Five control patients dropped out, 1 unable
to schedule a visit and 4 discontinued due to schedule
conflict, personal problems, losing interest or not eligi-
ble after baseline. Seven intervention patients discon-
tinued. Four were unable or unwilling to access web-
site, 1 schedule conflict, 1 patient had recurrent angina
and one moved out of the area
Selective reporting (reporting bias) Low risk All outcomes in methods are reported
Other bias Low risk No evidence of further bias
Vitacca 2009
Methods Randomised clinical trial
Participants 240 chronic respiratory patients, all of whom require home oxygen, some of whom
were on homemechanical ventilation, 101 with COPD were enrolled. Other reasons for
respiratory failure were Amyotrophic lateral sclerosis (a type of motor neurone disease),
restrictive chest disease or other neuromuscular disease. Inclusion criteria were also that
the patient had had at least one hospitalisation for respiratory illness in the previous year
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Vitacca 2009 (Continued)
Interventions Teleassistance program for patients and their familieswhohaveCOPD.The teleassistance
programme was based on a continuous 24 hour on-call service and pulse oximetry
available. Some patients received pulse oximetry with solid memory card and a modem
system for transmission through the home telephone line to the teleassistance nurse who
was available from 0800 to 1600 for 5 days a week to provide a real time teleconsultation.
Out of hours the pulmonologist on duty was contacted if needed
Control: traditional face-to-face care, i.e. out-patient follow-up regimen, discharge plans
did not include home nurse visits
Outcomes Reduction in hospitalisations.
Reduction in urgent GP calls.
Acute emergency department admissions.
Also costs after set-up equipment had been paid for.
Notes Some results were reported separately for COPD patients
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Using a set of computer-generated random numbers in 1:
1 ratio patients were assigned to the treatment or control
group”
Allocation concealment (selection bias) High risk The study reports no allocation concealment
Blinding (performance bias and detection
bias)
All outcomes
High risk Neither patients nor investigators were blinded to the allo-
cation of patients, nor were outcome assessors
Incomplete outcome data (attrition bias)
All outcomes
High risk Withdrawals were reported and some reasons given - the
data from these patients were not included in the analyses
Selective reporting (reporting bias) Low risk No evidence of selective reporting.
Other bias High risk All patients on long term oxygen therapy (LTOT) were con-
sidered together regardless of whether the cause of their de-
pendence was COPD, restrictive, amyotrophic lateral scle-
rosis, other neuromuscular or other disease. These causes
were not analysed separately
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Whitten 2007
Methods Randomised controlled trial, where qualitative data is also collected in detail
Participants Patients with a diagnosis of COPD and/or Congestive Heart Failure (CHF) who were
prescribed home health care services by their health insurance group were recruited.
Intervention group N = 83 and control group N = 78
Interventions Intervention: This group received a combination of traditional face-to-face home health-
care and virtual telemedicine visits
Control: This group received only conventional home care without virtual visits
Outcomes 1. The Short Form 36 (SF-36), Outcome and Assessment information Set (OASIS) and
patient charts were used to collect outcome data
2. Patient perceptions of the home telecare services were collected via telephone inter-
views, from the intervention group, in a qualitative piece of work
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “randomly assigned” but no details
Allocation concealment (selection bias) Unclear risk Insufficient information
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Insufficient information
Incomplete outcome data (attrition bias)
All outcomes
High risk As far as health outcomes were concerned
only patients with complete pre- and post-
data sets were included, i.e. this wasn’t an
intention-to-treat analysis. The study notes
problems with turnover of project nurses
and unwillingness to comply with data col-
lection protocols
Selective reporting (reporting bias) Low risk All outcomes specified in methods were re-
ported.
Other bias High risk The data of patients with COPD and CHF
were analysed together
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Wong 2005
Methods Randomised controlled study
Participants Patients: 60 participants with COPDwere recruited from an acute care hospital in Hong
Kong
Interventions Intervention: This study aimed to determine whether a nurse-led telephone follow-
up programme would increase patients’ self efficacy when it came to managing their
COPD dyspnoea. A person with high self efficacy feels more confident about engaging
in activities and makes more effort to overcome challenges. Two phone calls were made
in the first four weeks after discharge from hospital as this is felt to be a particularly
vulnerable time for patient re-admission
Control: control patients had routine care with no additional telephone input from
nurses
Outcomes 1. Self efficacy was measured by the Chinese Self Efficacy Scale
2. Number of visits to accident and emergency department.
3. Number of hospitalisations.
4. Unscheduled visits by physicians.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “randomised using the Research Randomizer software
which generated 30 sets of numbers.”
Allocation concealment (selection bias) Unclear risk Insufficient information
Blinding (performance bias and detection
bias)
All outcomes
Low risk “data were collected by a research assistant who was
blind to the grouping”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Four patients who refused to answer second questions
had their results replaced by the group mean. This may
not have been statistically appropriate
Selective reporting (reporting bias) Low risk All outcome measures stipulated in methods reported
in findings of
Other bias Low risk No evidence of other bias
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Aiken 2006 Management in hospital and COPD figures not separable
Balas 1997 Not asthma or COPD
Brooks 2002 Rehabilitation programme
Carrieri 2005 Not focusing on telehealthcare
Demiris 2003 Visits reviewed for technical quality
Donesky-Cuenco 2003 Exercise focused, not telehealthcare focused
Egan 2002 Not telehealthcare, hospital based case manager and discharge planner
Farrero 2001 Not telehealthcare - most visits were face-to-face
Gadoury 2005 Face-to-face visits
Griffiths 2005 Not telehealthcare - expert patient intervention face-to-face
Hernandez 2003 Not telehealthcare - home visits
Hibbert 2003 Not a randomised controlled trial - qualitative study
Hopp 2006 Patients had multiple conditions and COPD was not included
Jerant 2008 Not COPD separable
Jimison 2008 Includes studies of different chronic conditions and all types of literature. Not RCT
Mair 1999 Not a randomised controlled trial, small pilot study with 6 patients
Mair 2000a Not limited to COPD and results not fully reported but summarised
Mair 2002 Full text not available, despite extensive search and contact with author
Mair 2005 Outcome measures of interest in this study were not reported
Maltais 2005 Not telehealthcare - all interventions were face-to-face
Martens 2007 Not telehealthcare
Moore 2007 Exercise focused
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(Continued)
Moxam 2007 The Effects of a Home Exercise Video Programme for Patients With Chronic Obstructive Pulmonary
Disease, not telehealthcare
Oh 2003 Not COPD
Pare 2006 Non-randomised case-control study
Petty 2006 Video library
Poels 2008 GP practice-based
Rebuck 1996 The accuracy of a handheld portable spirometer, not telehealthcare
Ries 1995 Not telehealthcare
Ries 2003 Not telehealthcare
Sridhar 2008 Not telehealthcare
Tierney 2005 Not telehealthcare
Trappenburg 2008 Non-randomised controlled multicentre study
Wasson 1992 Unable to see COPD data
Welch 2000 Only 30% of patients were “mixed respiratory”, COPD patients were not identified
Whitten 2002 Covered multiple conditions
Characteristics of studies awaiting assessment [ordered by study ID]
ACTRN 12608000112369
Methods Interventional randomised controlled trial
Participants Participants will have a minimum age of 45 with COPD FEV1/FVC < 0.7 post-bronchodilator. Severity FEV1 30-
80% of predicted and greater than 10 pack year smoking history
Interventions Patients in the active arm will have an individual management plan developed by the research team. This will use
behaviour change and motivational interviewing techniques. Some of this plan will be delivered by nurses using the
telephone
Outcomes Quality of life, SF-36 and St George’s Respiratory Questionnaire, Depression scale, post-traumatic stress disorder
(PTSD) checklist, anxiety measure. Hospital Anxiety and Depression scale, Satisfaction with Life survey, Client Satis-
faction Questionnaire, lung function, spirometry, healthcare utilisation prescriptions for oral steroids and antibiotics,
physical activity as measured with accelerometer
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ACTRN 12608000112369 (Continued)
Notes Setting: University of Tasmania, Australia
ACTRN 12609000428268
Methods Randomised controlled trial to compare hospital admissions and emergency department visits in home care clients
with COPD undergoing telehealth home monitoring versus usual care
Participants Have a confirmed diagnosis of COPD and are currently receiving home oxygen services. Male and females over age
18 years
Interventions Remote home monitoring of client’s vital signs by a nurse will be undertaken via monitoring equipment installed in
the client’s home, including blood pressure, weight, heart rate, oxygen saturation levels. In addition, client’s responses
to questions regarding their general state of health, coughing and sputum production will be collected and forwarded
to the nurse who reviews them and gives advice including whether or not to involve a doctor
Outcomes Number of hospital admissions, number of emergency department visits and health related quality of life as measured
by this chronic respiratory questionnaire. Cost savings of home monitoring equipment compared to usual care
Notes Setting: Silver Chain Nursing Association, commercial sector, Western Australia
Alonso 2004
Methods Awaiting a home-care pilot in COPD
Participants The study is still at the proposed stage
Interventions An Integrated Chronic Care Platform that allows voice and data to be transmitted to the required healthcare profes-
sional regardless of his/her location
Outcomes Not yet specified
Notes This was very much a technical paper describing what was envisioned
Battaglia 2007
Methods Study still at the recruiting stage, only 77 patients enrolled so far
Participants Plans to enrol 600 patients for 24 months, 300 in control group 300 in intervention
Interventions Patients receive periodic nursing assistance and clinical monitoring by a general practitioner who is in contact with
a respiratory specialist at a call centre. Intervention patients also have hospital visits and analysis every three months
Outcomes Numbers of nursing accesses made, number of GP accesses and numbers of unscheduled visits and hospitalisations
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Battaglia 2007 (Continued)
Notes Difficulties in enrolment blamed on bureaucratic ethics committees and difficult co-ordination between hospital and
local health administrations
Battaglia 2008
Methods AIRTEM - Integrated Assistance by Respiratory TeleMedicine is a multicentred study carried out in Bilan to evaluate
the advantages of home telemonitoring patients with COPD and oxygen therapy. They plan to enrol 600 patients
over 24 months
Participants There are significant problems with slow recruitment due to problems with bureaucratic ethics committees and
difficult co-ordination
Interventions Following an initial visit to a respiratory specialist and entry of clinical data onto an Internet database the patients
will be seen by their GPs and by the specialists with have access to these records
Outcomes 77 patients enrolled by May 19 2008
Notes Ongoing
ISRCTN41424840
Methods Randomised controlled trial
Participants To be recruited for the study from the Prince Philip and West Wales General Hospital Pulmonary Rehabilitation
Scheme. The standard inclusion criteria to be accepted through the scheme for pulmonary rehabilitation is patients
who feel limited by their chest, have a primary physician, spirometric diagnosis of COPD, are on maximal respiratory
medication, have no unstable cardiac disease and no cognitive impairments
Interventions Patients in two groups will either receive standard care or 6 months telehealthcare support with doc@home which is
an integrated solution for the remote health management
Outcomes Are home electronic monitoring and electronic learning resources feasible and safe for patients with moderate to
severe COPD? Measured at baseline, 1 month and 6 months only. Does home telehealthcare reduce respiratory
hospital admissions? Reduce community specialist team visits? And improve quality of life and mood? And is home
telehealthcare telemedicine cost-effective?
Notes Setting: UK
ISRCTN96634935
Methods Randomised controlled trial with nested qualitative study
Participants Male and female participants with no age limits, registered to Lothian general practices admitted with an exacerbation
of COPD as the primary diagnosis to one of the three acute hospitals in Lothian in the previous year
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ISRCTN96634935 (Continued)
Interventions A modified touch screen computer with video capability which is linked by broadband to a secure N3 connection to
the Internet. Patients will be given a written management plan and an emergency supply of antibiotics and steroids.
Every morning the machine will monitor peak flow and oxygen saturation using validated instruments. This detail
will be sent to clinicians in charge of the patients. The respiratory team routinely survey the online data and contact
the patients if they have forgotten to send it or are unable to send it. If the information is outside the expected range
the clinicians can contact the patient to repeat measurements and institute management
Outcomes Time until first hospital admission up to one year post-randomisation, exacerbations and admissions including bed-
days, deaths, changes in medication, St Georges’ Respiratory Questionnaire, hospital anxiety and depression scale,
patient knowledge and self efficacy, lung function, patient engagement with procession. Cost effectiveness
Notes Trial setting in UK
Kalter-Leibovici 2009
Methods Randomized open label active control parallel assignment efficacy study
Participants Not yet open to participant recruitment
Interventions Disease management and home telemonitoring in addition to best care according to clinical guidelines for COPD
patients
Outcomes Hospital admission for acute exacerbation of COPD or all-cause mortality is the primary outcome. Secondary
outcomes are total days of hospitalisation for acute exacerbations of COPD, quality of life, total number of acute
exacerbations of COPD, depression, functional capacity, spirometry parameters
Notes Setting: Israel
Koff 2006
Methods Randomised pilot study
Participants 40 GOLD stage III and stage IV patients with COPD
Interventions An Internet-based eHealth device ’the Health Buddy’, spirometer, pedometer, oxygen saturation meter and other
peripheral devices
Outcomes St George’s Quality of Life Respiratory Questionnaire and costs of healthcare in US dollars, showed non significant
improvement in health status and saving in costs for intervention group
Notes Power calculations showed that a study in a larger group would be required to generate significant results
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NCT 00918905
Methods Prevention randomized open label parallel assignment trial
Participants Patients admitted acutely to the medical ward with an exacerbation of COPD
Interventions Patients were discharged within 24 hours with a computer with web cam, microphone, spirometry and saturation
monitoring equipment. A nurse used the equipment to observe the patient until their follow-up appointment 4 weeks
later
Outcomes Prevention of re-admission to hospital within 4 weeks of discharge, duration of hospital re-admission
Notes Setting: OUH Svenborg Hospital, Svendborg, Denmark
Prior 2009
Methods Randomized open label parallel assignment safety/efficacy trial
Participants Study not yet open for participant recruitment
Interventions Integrated health monitoring, alarm handling and videoconferencing systems compared with usual care alone to
delay transfer to nursing or elderly homes
Outcomes Health related quality of life as assessed by the SF 36 at 0, 15 and 30 months. Secondary outcomes include time to
permanent transfer to elderly homes, total and average length of stay in hospital, number of consultations with GPs
and medical specialists. No. of home visits by nurses and other secondary outcomes
Notes Setting: Belgium, patients with diabetes mellitus, chronic heart failure and chronic obstructive pulmonary disease
Troosters 2003
Methods Structured education, supported discharge by telephone contacts and intensified interactions with primary were
provided to the intervention group
Participants 42 patients admitted with acute exacerbations were randomly allocated to either usual care or intervention arm
Interventions The intervention consisted of education during hospitalisation and supported discharge - weekly contact with nurse
specialist and contact with general practitioner
Outcomes During the year of follow-up, 48% of supported discharge patients were re-admitted and 90% of usual care patients
were re-admitted. The median hospital free time was 388 days in telephone group and 86 days in the usual care
group, P = 0.016
Notes The authors concluded that this low cost intervention merits implementation in clinical routine
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Vandivier 2010
Methods Interventional treatment randomised open label, active control, parallel assignment, efficacy study
Participants Male and female over 40 years old with airflow obstruction on spirometry defined as FEV1/FVC less than or equal
to 70% and an FEV1 less than or equal to 50% predicted, or an FEV1 greater than 50% predicted with a history of
a COPD exacerbation within the previous year
Interventions Integrated care involving COPD specific education, self management instruction, remote monitoring and enhanced
communication with a co-ordinator
Outcomes Healthcare utilization over 9 months, quality of life by St. Georges Respiratory Questionnaire, guideline-based
medical therapy, exercise capacity, oxygen utilization and pre- and post-exercise oxygen saturations, BMI, obstruction,
dyspnoea, exercise capacity and symptoms on MMRC Dyspnea scale
Notes Undertaken in Colorado, USA in association with Kaiser Permanente and dept of veterans affairs
Characteristics of ongoing studies [ordered by study ID]
Brown 2009
Trial name or title Evaluation of programs of coordinated care and disease management COCA
Methods This is an extension of an original study in which 16 demonstration programs provided care coordination
services to beneficiaries with chronic illness in medicare’s fee for service program. A five-year CMS-funded
study tested whether the programs can improve patients’ use of medical services, improve outcomes and
satisfaction with care and reduce Medicare costs. The study also assessed physicians’ satisfaction with the
programs
Participants Had a variety of conditions including congestive heart failure, diabetes, coronary artery disease, COPD,
cancer, cerebrovascular disease, alzheimer’s disease, psychotic disorder and major depression
Interventions Behavioural intervention: care co-ordination consisting variously of nurse telephonic counselling nurse in-
patient home visits, home telemonitoring equipment and physician education and feedback
Outcomes Medicare program expenditures
Starting date Feb 15 2008
Contact information Study directors: Randal S Brown, Mathematica Policy research
and Carol A Magee, Centres from Medicare and Medicaid services
Notes
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Carrieri-Kohlman 2005
Trial name or title Internet-Based and Established Dyspnoea Self-Management Programs in COPD Patients
Methods Comparisons of electronic, Internet based dyspnoea self management program and face-to-face dyspnoea self
management program
Participants Age > 40 years, participants with mild COPD and ADL limited by dyspnoea, both genders
Interventions The twoprogramshave the same education exercise andmonitoring components, however, one is administered
via Internet the other is delivered face-to-face
Outcomes Dyspnoea, exercise adherence and performance, pulmonary exacerbations
Starting date Sept 2003
Contact information Carrieri-Kohoman at the University of California and Nguyen at the University of Washington
Notes This appears to be a record of the study which is published and covered in our “included studies” section
under Nyguyen
Finkelstein 2009
Trial name or title Effectiveness of Home Automated telemanagement in Chronic Obstructive Pulmonary disorder
Methods Randomized single blind (outcomes assessor) active control, parallel assignment efficacy study
Participants 280 participants, 21 years and older and understands spoken English, physician diagnosis of COPDmoderate
to severe COPD according to NHLB/WHO global initiative for COPD (GOLD) classification stages II to
III
Interventions Creation of a computer program that can help people learn about their COPD and how to manage it
themselves, then determination of whether the computer program, calledHome Automated Telemanagement
(HAT) helps patients with COPD in managing their disease and following their treatment plans
Outcomes Clinical health including lung function and respiratory symptoms, measured and baseline and every 3months
for 18 months. Disease specific quality of life, exercise tolerance, urgent health care utilization, self efficacy
for COPD patients and activities of daily living
Starting date December 2003
Contact information Joseph Finkelstein, John Hopkins University, Baltimore, Maryland, USA
Notes
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ISRCTN 18443546
Trial name or title Home telemonitoring for patients with COPD
Methods Randomised controlled cross-over trial
Participants 240 subjects living with a primary diagnosis of COPD identified from hospital admissions database. If they
have had two or more admissions to any of the following hospitals in the last two years: Prince Philip, West
Wales General, Withybush or Bronglais, participants must be at least 40 years old
Interventions 120 will be randomised to receive telemonitoring for 1 year whilst the other 120 receive standard care. After
1 year the telemonitoring will be swapped into the homes of the second group in a cross-over trial for 1 more
year of monitoring
Outcomes Number of hospital admissions, quality of life measures healthcare contacts (GP visits, nurse contacts etc.) a
cost evaluation will also be undertaken after the 2 years
Starting date ISRCTN date assigned 08/1/2010
Contact information De Keir Lewis Respiratory Centre, 01554-783133 or k.e.lewis@swansear.ac.uk
Notes Llanelli Wales
Jerant 2005
Trial name or title Homing in on Health, Study of a Home Delivered Chronic Disease Self Management Programme; A ran-
domised Trial of Home Self-Efficacy Enhancement
Methods There will be 3 groups comparing the effectiveness and cost effectiveness of two models of home care with
usual care to improve chronic illness outcomes. These will be in-person visits and telephone calls compared
with clinic visits
Participants Participantswill suffer fromdiabetesmellitus, congestive heart failure,COPD, asthma, arthritis anddepression
Interventions Home care will be delivered as above and will explore the mechanisms of effectiveness through its influence
on self efficacy and adherence
Outcomes Health related Quality of Life at 2 weeks and 4 weeks during the intervention, immediately post-intervention
and at 6 months and 12 months, secondary outcomes include self care and self efficacy at these time points
Starting date Dec 2005
Contact information Contacts: Anthony F Jerant, MD, Contact: Monique Moore Hill, BA
Notes Self efficacy is the beliefs patients have about their own abilities to successfully execute the actions required
to achieve valued health outcomes
41Telehealthcare for chronic obstructive pulmonary disease (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Mair 2001
Trial name or title Acute Chest Triage Rapid Intervention Guided by Home Care or Telecare (ACTRIGHT)
Methods A team of specialist nurses intercepts patients warranting admission with COPD exacerbation. They perform
clinical assessment of the patient’s suitability to be cared for at home. They are then randomised to either
telecare or face-to-face nurse home visits
Participants All COPD patients presenting to the A and E department of Aintree University Hospital or Royal Liverpool
Hospital were assessed for participation
Interventions Patients receive a medication package which includes antibiotics steroids and nebulised bronchodilators and
social service report if required until the patient is stable
Outcomes Clinical outcomes and costs
Starting date Ongoing
Contact information University of Liverpool
Notes Limited information available online
Victor 2008
Trial name or title A pilot study on the effect of telehealth on COPD patients in the Community
Methods
Participants
Interventions
Outcomes The number of emergency admissions owing to COPD in the intervention group as compared with the
control group
Starting date
Contact information Doncaster Central, East and West Primary Care Trusts and Bassetlaw Primary Care Trust
Notes No further information found
Whiteford 2002
Trial name or title Evaluation of the effect of a home-based cognitive-behavioural pulmonary rehabilitation programme on
physiological and psychosocial outcomes in COPD patients
Methods
Participants
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Whiteford 2002 (Continued)
Interventions
Outcomes Aerobic and functional capacity , activity levels health status, quality of life, dyspnoea rating, lung function,
self-efficacy, stage and process of behavioural change
Starting date
Contact information North Glasgow University Hospitals NHS Trust
Notes No further information
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D A T A A N D A N A L Y S E S
Comparison 1. Quality of life
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Quality of Life over 12 months 2 253 Mean Difference (IV, Random, 95% CI) -6.57 [-13.62, 0.48]
Comparison 2. Emergency department visits
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Number of patients with one
or more emergency dept
attendance over 12 months
3 449 Odds Ratio (M-H, Random, 95% CI) 0.27 [0.11, 0.66]
1.1 Telehealthcare studies 2 258 Odds Ratio (M-H, Random, 95% CI) 0.19 [0.03, 1.27]
1.2 Complex intervention
studies
1 191 Odds Ratio (M-H, Random, 95% CI) 0.40 [0.22, 0.71]
2 Number of patients with one
or more emergency dept
attendance over 3 months
1 60 Odds Ratio (M-H, Fixed, 95% CI) 0.17 [0.04, 0.67]
Comparison 3. Hospitalisations
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 No. of patients with one or more
hospitalisations in 12 months
4 604 Odds Ratio (M-H, Fixed, 95% CI) 0.46 [0.33, 0.65]
1.1 Telehealthcare 2 258 Odds Ratio (M-H, Fixed, 95% CI) 0.50 [0.29, 0.85]
1.2 Complex intervention
studies
2 346 Odds Ratio (M-H, Fixed, 95% CI) 0.44 [0.28, 0.68]
2 No. of patients entering a higher
level of care over 6 months
1 53 Odds Ratio (M-H, Fixed, 95% CI) 0.29 [0.08, 1.05]
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Comparison 4. Deaths over 12 months
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Deaths over 12 months 3 503 Odds Ratio (M-H, Fixed, 95% CI) 1.05 [0.63, 1.75]
1.1 Telehealthcare 1 157 Odds Ratio (M-H, Fixed, 95% CI) 1.32 [0.59, 2.97]
1.2 Complex intervention
studies
2 346 Odds Ratio (M-H, Fixed, 95% CI) 0.90 [0.46, 1.75]
2 Deaths over 6 months 1 53 Odds Ratio (M-H, Fixed, 95% CI) 0.73 [0.19, 2.71]
Analysis 1.1. Comparison 1 Quality of life, Outcome 1 Quality of Life over 12 months.
Review: Telehealthcare for chronic obstructive pulmonary disease
Comparison: 1 Quality of life
Outcome: 1 Quality of Life over 12 months
Study or subgroup Experimental Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Bourbeau 2003 96 50.6 (16.6) 95 54.6 (13.7) 66.2 % -4.00 [ -8.31, 0.31 ]
Casas 2006 21 37.8 (16.9) 41 49.4 (20.2) 33.8 % -11.60 [ -21.11, -2.09 ]
Total (95% CI) 117 136 100.0 % -6.57 [ -13.62, 0.48 ]
Heterogeneity: Tau2 = 14.68; Chi2 = 2.03, df = 1 (P = 0.15); I2 =51%
Test for overall effect: Z = 1.83 (P = 0.068)
Test for subgroup differences: Not applicable
-20 -10 0 10 20
Favours experimental Favours control
45Telehealthcare for chronic obstructive pulmonary disease (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 2.1. Comparison 2 Emergency department visits, Outcome 1 Number of patients with one or
more emergency dept attendance over 12 months.
Review: Telehealthcare for chronic obstructive pulmonary disease
Comparison: 2 Emergency department visits
Outcome: 1 Number of patients with one or more emergency dept attendance over 12 months
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Telehealthcare studies
de Toledo 2006 24/67 49/90 36.3 % 0.47 [ 0.24, 0.89 ]
Vitacca 2009 23/57 40/44 26.0 % 0.07 [ 0.02, 0.21 ]
Subtotal (95% CI) 124 134 62.3 % 0.19 [ 0.03, 1.27 ]
Total events: 47 (Experimental), 89 (Control)
Heterogeneity: Tau2 = 1.66; Chi2 = 8.27, df = 1 (P = 0.004); I2 =88%
Test for overall effect: Z = 1.72 (P = 0.086)
2 Complex intervention studies
Bourbeau 2003 39/96 60/95 37.7 % 0.40 [ 0.22, 0.71 ]
Subtotal (95% CI) 96 95 37.7 % 0.40 [ 0.22, 0.71 ]
Total events: 39 (Experimental), 60 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 3.09 (P = 0.0020)
Total (95% CI) 220 229 100.0 % 0.27 [ 0.11, 0.66 ]
Total events: 86 (Experimental), 149 (Control)
Heterogeneity: Tau2 = 0.49; Chi2 = 8.80, df = 2 (P = 0.01); I2 =77%
Test for overall effect: Z = 2.84 (P = 0.0046)
Test for subgroup differences: Chi2 = 0.54, df = 1 (P = 0.46), I2 =0.0%
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Analysis 2.2. Comparison 2 Emergency department visits, Outcome 2 Number of patients with one or
more emergency dept attendance over 3 months.
Review: Telehealthcare for chronic obstructive pulmonary disease
Comparison: 2 Emergency department visits
Outcome: 2 Number of patients with one or more emergency dept attendance over 3 months
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Wong 2005 3/30 12/30 100.0 % 0.17 [ 0.04, 0.67 ]
Total (95% CI) 30 30 100.0 % 0.17 [ 0.04, 0.67 ]
Total events: 3 (Experimental), 12 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 2.51 (P = 0.012)
Test for subgroup differences: Not applicable
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Analysis 3.1. Comparison 3 Hospitalisations, Outcome 1 No. of patients with one or more hospitalisations
in 12 months.
Review: Telehealthcare for chronic obstructive pulmonary disease
Comparison: 3 Hospitalisations
Outcome: 1 No. of patients with one or more hospitalisations in 12 months
Study or subgroup Interventions Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Telehealthcare
de Toledo 2006 31/67 59/90 27.2 % 0.45 [ 0.24, 0.86 ]
Vitacca 2009 40/57 35/44 11.9 % 0.61 [ 0.24, 1.53 ]
Subtotal (95% CI) 124 134 39.1 % 0.50 [ 0.29, 0.85 ]
Total events: 71 (Interventions), 94 (Control)
Heterogeneity: Chi2 = 0.25, df = 1 (P = 0.61); I2 =0.0%
Test for overall effect: Z = 2.57 (P = 0.010)
2 Complex intervention studies
Bourbeau 2003 31/96 48/95 32.9 % 0.47 [ 0.26, 0.84 ]
Casas 2006 29/65 60/90 28.0 % 0.40 [ 0.21, 0.78 ]
Subtotal (95% CI) 161 185 60.9 % 0.44 [ 0.28, 0.68 ]
Total events: 60 (Interventions), 108 (Control)
Heterogeneity: Chi2 = 0.11, df = 1 (P = 0.74); I2 =0.0%
Test for overall effect: Z = 3.70 (P = 0.00021)
Total (95% CI) 285 319 100.0 % 0.46 [ 0.33, 0.65 ]
Total events: 131 (Interventions), 202 (Control)
Heterogeneity: Chi2 = 0.50, df = 3 (P = 0.92); I2 =0.0%
Test for overall effect: Z = 4.49 (P < 0.00001)
Test for subgroup differences: Chi2 = 0.14, df = 1 (P = 0.71), I2 =0.0%
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Analysis 3.2. Comparison 3 Hospitalisations, Outcome 2 No. of patients entering a higher level of care over
6 months.
Review: Telehealthcare for chronic obstructive pulmonary disease
Comparison: 3 Hospitalisations
Outcome: 2 No. of patients entering a higher level of care over 6 months
Study or subgroup Interventions Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Finkelstein 2006 6/34 8/19 100.0 % 0.29 [ 0.08, 1.05 ]
Total (95% CI) 34 19 100.0 % 0.29 [ 0.08, 1.05 ]
Total events: 6 (Interventions), 8 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.89 (P = 0.059)
Test for subgroup differences: Not applicable
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Analysis 4.1. Comparison 4 Deaths over 12 months, Outcome 1 Deaths over 12 months.
Review: Telehealthcare for chronic obstructive pulmonary disease
Comparison: 4 Deaths over 12 months
Outcome: 1 Deaths over 12 months
Study or subgroup Intervention Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Telehealthcare
de Toledo 2006 14/67 15/90 35.8 % 1.32 [ 0.59, 2.97 ]
Subtotal (95% CI) 67 90 35.8 % 1.32 [ 0.59, 2.97 ]
Total events: 14 (Intervention), 15 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.67 (P = 0.50)
2 Complex intervention studies
Bourbeau 2003 5/96 9/95 30.3 % 0.53 [ 0.17, 1.63 ]
Casas 2006 12/65 14/90 33.9 % 1.23 [ 0.53, 2.87 ]
Subtotal (95% CI) 161 185 64.2 % 0.90 [ 0.46, 1.75 ]
Total events: 17 (Intervention), 23 (Control)
Heterogeneity: Chi2 = 1.39, df = 1 (P = 0.24); I2 =28%
Test for overall effect: Z = 0.32 (P = 0.75)
Total (95% CI) 228 275 100.0 % 1.05 [ 0.63, 1.75 ]
Total events: 31 (Intervention), 38 (Control)
Heterogeneity: Chi2 = 1.88, df = 2 (P = 0.39); I2 =0.0%
Test for overall effect: Z = 0.18 (P = 0.86)
Test for subgroup differences: Chi2 = 0.52, df = 1 (P = 0.47), I2 =0.0%
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Analysis 4.2. Comparison 4 Deaths over 12 months, Outcome 2 Deaths over 6 months.
Review: Telehealthcare for chronic obstructive pulmonary disease
Comparison: 4 Deaths over 12 months
Outcome: 2 Deaths over 6 months
Study or subgroup Intervention Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Finkelstein 2006 7/34 5/19 100.0 % 0.73 [ 0.19, 2.71 ]
Total (95% CI) 34 19 100.0 % 0.73 [ 0.19, 2.71 ]
Total events: 7 (Intervention), 5 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.48 (P = 0.63)
Test for subgroup differences: Not applicable
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